IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q4 2016 Holdings

Filed 2017-02-07 | 6 holdings | $118.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$66.2K3,489,53355.7%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$18.2K2,579,49015.4%
Ocular Therapeutix Inc(OCUL)COM67576A100$13.4K1,605,20711.3%
Catabasis Pharmaceuticals inCOM14875P107$10.3K2,857,6678.7%
Transenterix IncCOM NEW89366M201$9.8K7,546,6928.3%
Lombard MED IncCOMG55598109$7651,275,7790.6%